Current issues with procollagen III N-terminal peptide assay performance relevant to 2016 British Association for Dermatologist methotrexate-monitoring guidance-Reference-Cited by-同舟云学术

Current issues with procollagen III N-terminal peptide assay performance relevant to 2016 British Association for Dermatologist methotrexate-monitoring guidance

Published:2023-08-24 Issue:12 Volume:48 Page:1378-1379
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Taylor David R¹^ORCID,Stone Colin¹

Affiliation:

1. Department of Clinical Biochemistry (Synnovis), King’s College Hospital NHS Foundation Trust , London , UK

Abstract

Procollagen III N-terminal peptide (P3NP) testing is routinely used to detect possible liver fibrosis according to the cutoffs in the British Association of Dermatologists (BAD) 2016 guidelines for the safe and effective prescribing of methotrexate in skin disease. We report significant changes to P3NP test performance that will potentially change patient management according to the BAD 2016 guidelines.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://academic.oup.com/ced/advance-article-pdf/doi/10.1093/ced/llad287/51557037/llad287.pdf

Reference5 articles.

1. British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016;Warren;Br J Dermatol,2016

2. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients;Boffa;Br J Dermatol,1996

3. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis;Chalmers;Br J Dermatol,2005

4. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic;Barker;J Eur Acad Dermatol Venereol,2011

5. Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis;Maybury;Br J Dermatol,2014